View in EDS PDF Full Text

Preliminary efficacy of pembrolizumab plus lenvatinib in recurrent clear cell gynecological cancer: Phase II LARA trial (GCGS-OV4/APGOT-OV3).

Saved in:
Bibliographic Details
Title: Preliminary efficacy of pembrolizumab plus lenvatinib in recurrent clear cell gynecological cancer: Phase II LARA trial (GCGS-OV4/APGOT-OV3).
Authors: Byoung-Gie Kim1 bgkim@skku.edu, Chel Hun Choi1, Ngoi, Natalie2, Tan, David2, Jae-Weon Kim3
Source: Journal of Gynecologic Oncology. 2024 Supplement, Vol. 35, p31-32. 2p.
Database: Academic Search Ultimate
Description
ISSN:20050380
DOI:10.3802/jgo.2024.35.S2.P21